{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:15:28Z","timestamp":1794273328427,"version":"4.9.0"},"reference-count":42,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T00:00:00Z","timestamp":1607126400000},"content-version":"unspecified","delay-in-days":339,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Santen GmbH","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Market Access &amp; Health Policy"],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1080\/20016689.2020.1748492","type":"journal-article","created":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T16:31:31Z","timestamp":1586017891000},"page":"1748492","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score"],"prefix":"10.3390","volume":"8","author":[{"given":"Andrea","family":"Leonardi","sequence":"first","affiliation":[{"name":"Ophthalmology Unit, Department of Neuroscience, University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00ebva","family":"Dupuis-Deniaud","sequence":"additional","affiliation":[{"name":"MDSTAT Consulting, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bremond-Gignac","sequence":"additional","affiliation":[{"name":"Hospital Necker Enfants Malades, APHP, and CNRS Unit FR 3636, Paris Descartes University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,4]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e328364ec7a"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12197"},{"key":"cit0003","unstructured":"Kraus, Courtney.Vernal Keratoconjunctivitis. American academy of Ophthalmology; 2016 [cited 2019 Nov 12].Available from: https:\/\/www.aao.org\/disease-review\/vernal-keratoconjunctivitis-5"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-301376"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00622.x"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.117812"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.10.042"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-019-0656-4"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e3282efb726"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.06.028"},{"key":"cit0011","unstructured":"Santen. The QANT study. Vernal Keratoconjunctivitis Physician Survey; 2017 June."},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-013-0019-y"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00092-0"},{"key":"cit0014","unstructured":"VERKAZIA.Summary of product characteristics(SmPC). [cited 2019 Nov 13]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/verkazia-epar-product-information_en.pdf."},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1111\/all.13786"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-013-0345-0"},{"key":"cit0017","unstructured":"Pisella P-J, Baudouin C, Hoang-Xuan T. Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Ophtalmologie-Rapport 2015 SURFACE OCULAIRE. art. L. 122-4, L. 122-5 et L. 335-2. [cited 2019 Nov 13] Available from: https:\/\/www.em-consulte.com\/em\/SFO\/2015\/html\/index.html"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.5679"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2012.07.001"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.122044"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1007\/s40521-014-0040-y"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.12.027"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001200"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.5935\/0004-2749.20170045"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12360"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000001"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2009.00948.x"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200310000-00008"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-311171"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/37145"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-300415"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.05.035"},{"key":"cit0033","unstructured":"European Medicines Agency. Follow-up protocol assistance, Ciclosporin (VEKACIA). 2012 Apr 19. (EMA\/CHMP\/SAWP\/225272\/2012)."},{"key":"cit0034","unstructured":"European Medicines Agency. Positive opinion of the paediatric committee on compliance with a paediatric investigation plan. 2016 Apr 29. (EMEA-C-000575-PIP01-09-M03)."},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01347.x"},{"issue":"3","key":"cit0036","first-page":"160","volume":"66","author":"Brown M","year":"1999","journal-title":"Mt Sinai J Med"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.11.043"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38629"},{"key":"cit0039","doi-asserted-by":"crossref","unstructured":"Roever L Endpoints in clinical trials: advantages and limitations. Evidence based medicine and practice 1: e111.2016. [cited 2019 Nov 13]. Available from: https:\/\/www.omicsonline.org\/open-access\/endpoints-in-clinical-trials-advantages-and-limitations-ebmp-1000e111.pdf","DOI":"10.4172\/2471-9919.1000e111"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1017-5"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225010-00004"},{"key":"cit0042","unstructured":"European Medicines Agency.Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases. 2008 Nov 20. (CHMP\/EWP\/18504\/2006)."}],"container-title":["Journal of Market Access &amp; Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20016689.2020.1748492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T09:02:57Z","timestamp":1705568577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/search?q=10.1080\/20016689.2020.1748492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"alternative-id":["10.1080\/20016689.2020.1748492"],"URL":"https:\/\/doi.org\/10.1080\/20016689.2020.1748492","relation":{},"ISSN":["2001-6689"],"issn-type":[{"value":"2001-6689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=zjma20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=zjma20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}